drugset / Trial / NCT02788357

Post-stroke Neural Plasticity With Atomoxetine

NCT02788357

Phase 2 Completed 12 enrolled Lumy Sawaki
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This proposal evaluates the safety and effectiveness of a noradrenergic drug named atomoxetine combined with motor training to enhance cortical plasticity and improve hand function after stroke.

Timeline

Start
2006-11
Primary completion
2012-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified 40 mg Oral

Indications

No indication recorded.